Although cells of the immune system can produce thyroid-stimulating hormone (TSH), the significance of that remains unclear. Using 5 0 rapid amplification of cDNA ends (RACE), we show that mouse bone marrow (BM) cells produce a novel in-frame TSHb splice variant generated from a portion of intron 4 with all of the coding region of exon 5, but none of exon 4. The TSHb splice variant gene was expressed at low levels in the pituitary, but at high levels in the BM and the thyroid, and the protein was secreted from transfected Chinese hamster ovary (CHO) cells. Immunoprecipitation identified an 8 kDa product in lysates of CHO cells transfected with the novel TSHb construct, and a 17 kDa product in lysates of CHO cells transfected with the native TSHb construct. The splice variant TSHb protein elicited a cAMP response from FRTL-5 thyroid follicular cells and a mouse alveolar macrophage (AM) cell line. Expression of the TSHb splice variant, but not the native form of TSHb, was significantly upregulated in the thyroid during systemic virus infection. These studies characterize the first functional splice variant of TSHb, which may contribute to the metabolic regulation during immunological stress, and may offer a new perspective for understanding autoimmune thyroiditis.
Introduction
Thyroid-stimulating hormone (TSH), along with luteinizing hormone, follicle stimulating hormone and chorionic gonadotropin are members of a family of glycoprotein hormones. Glycoprotein hormones consist of a common a-subunit and unique b-subunits, the latter being responsible for hormone specificity. 1, 2 As would be expected for molecules that are highly conserved evolutionarily, there is considerable homology at both the gene and protein levels between human and mouse TSHb. In both species, the TSHb polypeptide consists of 138 amino acids of which 20 amino acids comprise the signal peptide and 118 constitute the mature protein. 3 Overall, there is 82% homology at the nucleic acid level and 88% homology at the amino acid level between human (accession no. NM_000549) and mouse (accession no. NM_009432) TSHb. The mouse TSHb gene consists of 5 exons, with the coding region located in portions of exons 4 and 5. 3 At present, the only evidence for alternative exon splicing for mouse TSHb is in exons 1, 2 and 3, 4,5 all of which are outside the TSHb-coding region. No evidence yet exists for alternative splicing of TSHb either within the coding region itself, or in ways that affect expression of the TSHb protein.
The thyroid hormones, thyroxine (T4) and triiodothyronine (T3), are essential deterministic factors that influence nearly every aspect of mammalian physiology, including basal metabolism, growth, development, mood and cognition. TSH induces thyroid hormone synthesis by promoting the proteolytic conversion of thyroglobulin to T4 and T3 in thyroid follicles. Levels of thyroid hormones are controlled by the presence of circulating pituitary-derived TSH; feedback mechanisms, in particular T4 levels, modulate TSH synthesis through hypothalamic-derived thyrotropin-releasing hormone. 1, 6 The fact that there are extra-pituitary sources of TSH, including TSH produced by cells of the immune system has been known for over 20 years. [7] [8] [9] Although TSH may have some activity as an immunoregulatory/cytokinelike molecule within the immune system, [10] [11] [12] [13] several observations now point to a more direct link between immune system TSH and the hypothalamus-pituitary-thyroid axis. For example, hypophysectomized mice challenged with foreign antigen have increased circulating T4. 14 In as much as the elevated levels of T4 in hypophysectomized mice could not be accounted for through classical pituitary-thyroid circuitry, this suggested that an extrapituitary source of TSH was responsible. Additionally, TSH has been shown to be actively produced by a subset of CD11b þ bone marrow (BM) cells. 15 Moreover, following adoptive transfer of CD11 þ BM cells from enhanced green-fluorescent protein (EGFP) transgenic mice into non-EGFP mice, EGFP þ cells traffic to the thyroid where they express TSH transcripts and secrete TSH. 16 As part of our studies aimed at gaining a better understanding of the role of immune system-derived TSH, we conducted a comprehensive examination of murine BM mRNA using a panel of TSHb primers. These studies revealed significant differences in gene expression in the BM compared with the pituitary in the 5 0 region of TSHb mRNA in exons 3 and 4. Using 5 0 rapid amplification of cDNA ends (RACE), we have identified a novel in-frame TSHb splice variant that is preferentially expressed in BM cells related to native TSHb. This isoform, the first functional alternatively spliced form of murine TSHb to be identified, is upregulated in thyroid tissues following systemic virus infection.
Results
Quantitative real-time PCR (qRT-PCR) and 5 0 RACE analyses identify a novel TSHb splice variant expressed in BM hematopoietic cells The full-length mRNA sequence is shown in Figure 1a , which indicates the positions of the five mouse TSHb exons (designated E1-E5), with the translated portion beginning with the ATG (bolded) at the second nucleotide of exon 4. The signal peptide is coded for by the region highlighted in blue; the translated portion of the mature peptide is highlighted in green; the location of the stop codon (TAA) is bolded.
Quantitative RT-PCR analysis was performed using primers targeted to several regions of mouse TSHb mRNA. A primer set designated '470' was used for PCR amplification with pituitary and BM RNAs. Those primer sequences, which span the TSHb-coding region, are targeted to a region in exons 3 (470-5 0 ) and 5 (470-3 0 ; Figure 1a ). Using the 470 primer set, we consistently observed a marked difference (26 987-fold greater) in the amount of amplified product for pituitary vs BM RNA (Figure 1b Novel immune system TSH BH Vincent et al formed using two primer sets targeted to exon 5 (98-5 0 -98-3 0 , and Superarray; Figure 1a ), the fold difference in gene expression between pituitary vs BM was 648 and 439, respectively (Figure 1b ). This represented a statistically significant (Po0.01) 62.8-fold reduction (34 019 vs 543) in the relative gene expression of the ratio of pituitary/BM TSHb expression using upstream primer sequences targeted to exons 3 or 4 compared to primers targeted to exon 5 ( Figure 1b) .
We hypothesized that the qRT-PCR differences between BM and pituitary RNAs as a function of the primer target location were because of an alternative splicing of the TSHb gene at or near the junction of exons 4 and 5. To obtain a sequence of BM TSHb mRNA from that region, the 5 0 RACE analysis was performed using a highly purified preparation of BM RNA. RACE technology insured that only full-length, nontruncated mRNAs were used. A sequence, which was consistently obtained in multiple 5
0 RACE cDNA clones, is shown in Figure 1c ATG comprises an open reading frame with a Kozak sequence consisting of the ATC nucleotides before the ATG triplet. Thus, these data point to a modified splicing mechanism for BM TSHb, and they explain the low levels in PCR product from BM RNA using upstream primer sequences targeted to exons 3 or 4 vs the abundance of product using primers targeted to exon 5.
Relative to the expression of native TSHb, the TSHb splice variant is expressed at low level in pituitary cells but at high level in BM and thyroid cells Conventional and RT-PCR analysis were performed to determine whether the novel TSHb splice variant was expressed in pituitary, BM, and/or thyroid tissues. For this, a new primer set designated 'novel primers' (Table 1 and Supplementary Figure S1a ) was used consisting of a 24 nucleotide upstream primer targeted to intron 4, and a downstream primer targeted to a sequence located just after the TAA stop codon of exon 5. If present, the novel TSHb transcript would be amplified using these primers. Figure 2a indicates the relative gene expression levels using the 470 primer set and the TSHb novel primer set. By conventional PCR, transcript levels using the 470 primers were detectable only in pituitary RNA ( Figure 2a , top panel), whereas the novel TSHb transcript was present in all three tissues-the pituitary, the BM, and the thyroid. These findings were confirmed by qRT-PCR (Figure 2b ), which indicated an overwhelming preference for the native TSHb using the 470 primer set with pituitary vs BM or thyroid RNA. In contrast, the amount of levels of qRT-PCR amplification were more similar in those three tissues (Figure 2b ), implying that there is a preferential use of the novel TSHb splice variant in the BM and thyroid.
Because the novel TSHb product was generated using an upstream primer targeted to a sequence of intron 4, experiments were carried out to rule out the amplification that had occurred from genomic DNA. Three experiments confirmed that the amplification was not because of genomic DNA. First, if genomic DNA were present, amplification with the 470 primer sets would yield larger PCR products because of the presence of introns 3 and 4. As seen in Figure 2a (top panel), all three samples were devoid of PCR products larger than the anticipated nucleotide size of 470. Second, when BM RNA was tested in a one-step PCR reaction in the absence or in the presence of reverse transcriptase using the novel upstream primer, a PCR product was obtained only in the presence of reverse transcriptase and not in Table 1 Primers used in this study
Primer designation
Sequence
Novel TSH reverse Abbreviations: GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GSP, gene-specific primer; TSH, thyroid-stimulating hormone; RACE, rapid amplification of cDNA ends.
the absence of reverse transcriptase (Figure 2c ). Third, using four upstream primer sequences targeted to regions of intron 4 (Supplementary Figure S1b) , all yielded products of the correct size from genomic DNA, but only the two primers for regions at the beginning of the RACE sequence yielded products from Figure 2 Native TSHb is expressed at high levels in the pituitary but not in the bone marrow or in the thyroid, whereas the novel TSHb splice variant is expressed in all three tissues. (a) PCR and agarose gel electrophoresis analysis of pituitary, bone marrow and thyroid RNA using the 470 primer set that spans the TSHb-coding region yielded a product that was evident only from pituitary RNA. In contrast, using primers (see Supplementary Figure S1a ) for the novel TSHb splice variant, a PCR product of the anticipated size was obtained using RNA from all three tissues. (b) qRT-PCR was used to compare the ratio of the 470 PCR product and the novel splice variant product of pituitary/ BM and pituitary/thyroid. Using the 470 primer set, there was an extremely high preference for expression of native TSHb in the pituitary relative to the BM and thyroid. Using the novel primer set, however, the ratio of pituitary/BM and pituitary/thyroid was substantially lower. (c) To confirm that amplification using the novel primer set had not occurred from the genomic DNA, a one-step PCR reaction was performed in which reverse transcriptase was included or omitted. Note that amplification occurred only in the presence of reverse transcriptase, thus excluding the possibility that contaminating genomic DNA was present. (d) The presence of contaminating genomic DNA was also ruled out using four upstream primers targeted to intron 4 (see Supplementary Figure S1b ). Amplification using those primers with the 98-3 0 primer with genomic DNA yielded four PCR products of the anticipated sizes. In contrast, PCR products were obtained from BM RNA only with intron primers 1 and 2, both of which target a region near the 5 0 RACE start site. These findings also confirm that the data shown in Novel immune system TSH BH Vincent et al BM RNA (Figure 2d) . The latter not only confirmed the lack of genomic DNA in RNA preparations, but it also validated the 5 0 RACE findings as accurately defining the beginning of the BM TSHb splice variant.
-
The novel TSHb protein is an actively secreted protein The physiochemical characteristics of the novel TSHb polypeptide predicted from the nucleotide sequence is shown in Figure 3 . This consists of a 9-amino-acid leader sequence followed by an 84-amino acid polypeptide of the mature protein molecule coded for by exon 5 up to the TSHb stop codon (Figure 3a) . The difference between the novel TSHb polypeptide (Figure 3b, red) and the native TSHb molecule is the lack of amino acids coded for by exon 4. The secondary structure of the novel TSHb splice variant is shown in Figure 3c , Note the high hydrophobic moment index (gray line; 43.0) and the high transmembrane helix preference (red line; 2.0) for the first 9-amino acids, thus favoring a transmembrane location and a likely signal peptide function. Importantly, cell-free supernatants from Chinese hamster ovary (CHO) cells transfected with native and splice variant TSHb constructs had high levels of TSHb as detected by reactivity with an antimouse TSHb-specific monoclonal antibody 17 ( Figure 3d ). Supernatants from control CHO cells transfected with a LacZ construct were nonreactive with the anti-TSHb antibody. As CHO cells were not transfected with the TSHa gene, it is assumed that the observed activity is due to TSHb alone. These findings collectively indicate that the novel TSHb product is actively secreted from cells.
Immunoprecipitation was performed using an antiTSHb antibody directed to a portion of the molecule that is shared by both native and novel TSHb to confirm that transfected CHO cells produced TSHb of the correct molecular size. Cell lysates from nontransfected CHO cells were nonreactive by immunoprecipitation (Figure 3e ). Immunoprecipitation of cell lysates from CHO cells transfected with the native TSHb construct produced a 17 kDa product; a 8 kDa product was precipitated from lysates of CHO cells transfected with the novel TSHb construct (Figure 3e ).
The TSHb splice variant is biologically active and is upregulated in the thyroid during systemic virus infection
Recombinant native and splice variant proteins were also used to evaluate their ability to induce a cAMP response from the mouse alveolar macrophage (AM) cells and rat FRTL-5 cells. As described in the Materials and methods, cAMP activity was assayed in cell supernatants after 3 h of TSH stimulation. Mouse AM cells were confirmed to express the TSH receptor by RT-PCR (data not shown). Culture of AM cells with recombinant native and splice variant TSHb induced a cAMP responses with native TSHb having peak activity at a concentration of 10 À10 M, and splice variant TSHb having peak activity at a concentration of 10 À6 M (Figure 4a ). Differences in those responses as a function of TSH concentration may reflect differences in receptor-binding activities. Future studies are planned to examine this possibility.
Using FRTL-5 cells, both native and the novel TSHb splice variant induced dose-dependent cAMP responses (Figure 4b) . Moreover, the optimal molar concentrations for these responses (10 À10 -10 À12 ) were typical of TSH concentration used by others to induce cAMP responses in vitro. 18 The cAMP response induced by recombinant TSHb proteins, although low, were generally in line with some reports of cAMP responses from FRTL-5 cells. 19 A lower cAMP response from FRTL-5 cells also may be because of poor binding of mouse TSH to rat FRTL-5 cells, an interpretation that is supported by the fact that bovine TSH generated a stronger cAMP response from FRTL-5 cells (8.83 and 7.75 pmol ml À1 cAMP following stimulation with 10 À7 and 10 À9 M bovine TSH, respectively). Collectively, these findings confirm that the polypeptide made from the TSHb splice variant is biologically active with regard to its ability to induce a cAMP signal.
Given our previous studies demonstrating that TSHproducing BM cells migrate to the thyroid, 16 we were interested in determining whether immune challenge by virus would result in changes in intrathyroidal levels of native and/or splice variant TSHb. C57BL/6 mice were infected i.p. with 10 7.5 plaque forming units (PFU) T3D reovirus. The rationale for using reovirus was on the basis of studies demonstrating altered thyroid function following reovirus infection. 20, 21 Thyroid tissues were isolated 48 h later; RNA was extracted, and qRT-PCR was performed using the 470 and the novel TSHb primer sets. Systemic virus infection did not alter the level of native TSHb gene expression in the thyroid related to that of noninfected mice; however, there was a statistically significant increase in gene expression of the TSHb splice variant in the thyroid of virus-infected mice (Figure 4b ). These findings suggest that the intrathyroidal host response is linked to the TSHb splice variant, but not the native form of TSHb.
Discussion
This study has identified the first functionally active splice variant of mouse TSHb. The novel nature of this isoform, involving the retention of a portion of intron 4, makes it particularly intriguing. Splice variants that incorporate intronal pieces, [22] [23] [24] [25] [26] [27] though once thought to be uncommon, appear to occur at a higher frequency than previously believed, possibly occurring in upwards of 15% of human and mouse genes. 28, 29 However, most such splicing events are associated with disease conditions or with tumor cells, and they frequently result in truncated proteins or aborted translation because of the generation of a stop codon. 30 The splice variant described here consists of a portion of intron 4 and it includes all of the coding region of exon 5, but none of exon 4, thereby coding for a polypeptide that corresponds to 71.2% of the mature native TSHb molecule. Interestingly, exon 5 of TSHb, the coding portion retained in the novel TSHb slice variant, is important for the biological function of TSH as it includes an 18-amino-acid 'seatbelt' region (CNTDNSDCIHEAVRTNYC) that is used for attachment to the a-subunit. This suggests that the splice variant may retain the ability to function as a heterodimeric complex.
Using an adoptive cell transfer system involving EGFP BM cells injected into non-EGFP mice, we have demonstrated that some BM cells consistently traffic to the thyroid of healthy animals. 16 Trafficking also occurred using CD11b þ EGFP cells that were matured from BM cells by in vitro culture for 6 days with granulocyte-macrophage colony-stimulating factor and injected into nonirradiated, non-EGFP recipient mice; twenty-five days later, there was an abundance of EGFP þ cells surrounding thyroid follicular areas. 16 In those studies, donor EGFP þ cells were documented to produce TSHb in situ by immunocytochemical staining. At that time, we were unaware of the splice variant form of TSHb, and the anti-TSHb antibody used was generated to 12 aminoacid residues of TSHb that are coded for by exon 5. As such, that antibody would not discriminate between native and splice variant forms of TSHb. In this study, it is clear that the novel TSHb splice variant is preferentially expressed in the BM and the thyroid (Figures 2b and c) , and that gene expression increases in the thyroid following systemic virus infection (Figure 4b ). As the BM cells appear to be a primary source of TSHb in the thyroid, 15, 16 the most likely interpretation of our findings is that the higher level of TSHb gene expression is either because of an increase in TSH synthesis by resident BM cells in the thyroid, or because of the increased trafficking of BM cells to the thyroid during infection.
There are several potential ways in which immune system TSH might serve to regulate thyroid hormone activity. On the one hand, it could function agonistically to elicit a thyroid hormone response leading to the increases in T3 and T4 synthesis and an upregulation in cellular and physiologic metabolic activity. The fact that the TSHb splice variant was capable of inducing a cAMP response provides some support for this possibility. Conversely, it is possible that the TSHb splice variant has an antagonistic activity, which serves to restrict thyroid hormone synthesis by binding to and competing for TSH receptor signaling. Clearly, considerably more work will be needed to discriminate between these two possibilities in the context of both normal physiological conditions and in various pathological states. However, because the immune system is vested with the capacity to detect a wide range of threats to the health of the organism, including challenge because of acute and chronic infection, malignant conditions and debilitating conditions, such as coronary disease, the network described here provides an additional source of information that is not typically incorporated in sensory processing by the neuroendocrine system. Microregulation of thyroid hormone activity by immune system TSH may be important for adjusting to altered metabolic demands during times when energy conservation is needed. Finally, it should be noted that a system such as this could have negative consequences for the host, particularly if the TSHb splice variant displays an enhanced potential for immunogenicity relative to native TSHb. Local intrathyroidal production of the TSHb splice variant under the scenario described above may inadvertently lead to the generation of anti-TSH autoantibodies and autoimmune thyroiditis, as it can occur following systemic virus infection. 21 
Materials and methods

Mice
The 6-8-week-old female C57BL/6 mice were purchased from Harlan Sprague-Dawley (Indianapolis, IN, USA). Mice were used in accord with the University of Texas Health Science Center institutional animal welfare guidelines.
RNA isolation and PCR analyses
Quantitative RT-PCR analysis was performed using RNA isolated with an RNAeasy Protect Mini Kit-50 (Qiagen, Valencia, CA, USA); samples were treated with DNase using an RNase-Free DNase Set-50 (Qiagen) according to the manufacturer's protocols. RNA concentrations were determined at A 260 . Primer sets were purchased from IDT Technologies (Coralville, IA, USA) or Superarray Bioscience Corp. (Frederick, MD, USA). qRT-PCR was performed on 100 ng total RNA using an iScript One-step RT-PCR kit with SYBR Green (Bio-Rad, Hercules, CA, USA). A blank sample with RNase-free water was used for primer controls. Amplification was performed in 96-well thin wall plates sealed with optical quality film in a Mini-Opticon (Bio-Rad) with a program of 10 min at 50 1C for cDNA synthesis, 5 min at 95 1C for reverse transcriptase inactivation, followed by 45 cycles of 95 1C for 10 s and 55 1C for 30 s for data collection. A melt curve was performed using a protocol of 1 min at 95 1C and 1 min at 55 1C, increasing the temperature in 0.5 1C increments for 80 cycles of 10 s each. Real-time PCR data were quantified using the 2 ÀDDCt method of Livak and Schmittgen; 31 samples were normalized to respective GAPDH values using a Gene Expression Macro Version 1.1 program (Bio-Rad).
The 5
0 RACE, cloning, sequencing and generation of recombinant proteins The 5 0 RACE was performed using a GeneRacer Kit (Invitrogen, Carlsbad, CA, USA). Briefly, highly pure RNA isolated from BM cells was dephosphorylated with calf intestinal phosphatase to insure that only full-length nontruncated mRNA was used. RNA was treated with tobacco acid pyrophosphatase to remove the 5 0 cap structure from intact full-length mRNA. A 5 0 RACE Oligo provided with the kit was ligated to the 5 0 end of the mRNA. The ligated mRNA was reverse transcribed using SuperScript III reverse transcriptase to create a RACE-ready first strand cDNA. The cDNA was amplified using Platinum Pfx DNA polymerase with the 5 0 RACE Oligo primer and a TSH gene-specific primer. The RACE PCR products were purified using a simple nucleic acid pres (SNAP) column provided with the kit. PCR products were cloned into a pCR4BLUNT-TOPO vector using a TOPO cloning kit (Invitrogen). Chemically competent Escherichia coli were transformed with 4 ml of the 5 0 RACE PCR product; transformed cells were selected on the basis of kanamycin resistance. The clones were grown overnight in Luria broth in the presence of kanamycin. Plasmid DNA was purified using a Qiagen QIAprep Spin Miniprep Kit (Qiagen Inc., Valencia, CA, USA). Sequencing was performed by Seqwright Inc. (Houston, TX, USA) using M13 primers.
To obtain recombinant proteins, native TSHb and splice variant TSHb DNAs were subcloned into pcDNA3.1/V5-His-TOPO vectors. Plasmid DNA was obtained using standard methods. CHO cells grown in serum-free CHO-CD media (Sigma-Aldrich, St Louis, MO, USA) were transfected with native or novel plasmid DNA using an Amaxa electroporator (Amaxa Biosystems, Gaithersburg, MD, USA). Cells were selected for stable tranfectants by continuous culture in 1.2 mg ml À1 neomycin. A total of 10 7 cells were used to purify His-tagged recombinant proteins using a NI-NTA Fast Start Kit (Qiagen). Estimate of protein concentration was determined using a Coomassie Plus-200 Protein assay (Pierce, Rockford, IL, USA). Recombinant proteins were stored at À80 1C in the presence of 0.5% bovine serum albumin for stabilization.
cAMP assay FRTL-5 cells were obtained from American Type Culture Collection (Manassas, VA, USA). The mouse AM cells line, AMJ2-C8 (American Type Culture Collection) was a gift from Dr Chinnaswamy Jagannath, Department of Pathology, The University of Texas Health Science Center at Houston. FRTL-5 cells were grown in Dulbecco's modified eagle media supplemented with 10% FBS, 2 mM L-glutamine, 10 mg ml À1 insulin, 10 nM hydrocortisone, 5 mg ml À1 transferin, 10 ng ml À1 gly-his-lys-acetate, 10 ng ml À1 somatostatin and 10 mU ml À1 bovine TSH (Sigma-Aldrich). AM cells were grown in defined serum-free hybridoma medium (Gibco-Invitrogen, Carlsbad, CA, USA) supplemented with 2 mM L-glutamine. Five to seven days before stimulation with native and splice variant TSHb, media lacking bovine TSH was used for FRTL-5. FRTL-5 cells were grown to 80% confluency in 24-well Corning tissue culture plates (Fisher Scientific, Pittsburgh, PA, USA); AM cells were grown to a density of 1-2 Â 10 6 ml
À1
. As described by others, 18 FRTL-5 cells were washed twice with Hank's balanced salt solution containing 0.4% BSA, 220 mM sucrose and 1 mM isobutylmethylxanthine (Sigma). AM cells were washed and seeded at a density of 1 Â 10 6 cell per ml in 1.5 ml eppendorf tubes. Log 10 M dilutions of recombinant native TSHb, splice variant TSHb, forskolin or media for control cultures was added for 3 h at 37 1C in a humidified 5% CO 2 incubator. Cell-free supernatants were collected and assayed for cAMP activity using a commercial assay kit (R&D Systems, Minneapolis, MN, USA).
Immunoprecipitation
A total of 2 Â 10 6 nontransfected CHO cells, CHO cells transfected with native TSHb and CHO cells transfected with splice variant TSHb were lysed on ice for 15 min in a buffer consisting of 50 mM Tris-HCL (pH 7.4), 150 mM NaCl, 1 mM EGTA, 2 mg ml À1 aprotinin 1 mg ml À1 leupeptin and 1 mM phenylmethyl sulfonyl fluoride (Sigma, all reagents). Lysates were clarified by high-speed centrifu-gation in a microfuge for 5 min. Supernatants were collected and precleared by end-over-end mixing overnight with 50 ml of protein G-plus agarose (Santa Cruz Biotechnologies, Santa Cruz, CA, USA). Protein G was removed from lysates by three successive centrifugation. Lysates were reacted by end-over-end mixing for 1 h at 4 1C with 25 ml of anti-TSHb antibody (N-19) (Santa Cruz) adsorbed to protein G. Protein G immune complexes were washed with lysis buffer and suspended in 30 ml of Laemmli sample buffer (Bio-Rad, Hercules, CA, USA) containing 5% b-mercaptoethanol, boiled for 5 min and electrophoresed though a precast 12% polyacrylamide gel (Bio-Rad). Gels were fixed and exposed to silver staining using the reagents and methods of M Barton Frank (http://omrf.ouhsc.edu/~frank/SILVER.html).
Enzyme-linked immunoassay
Because there are no commercially available mouse TSH enzyme-linked immunoassays, the enzyme-linked immunoassay used in this study was similar to a procedure developed and published by our laboratory using an antimouse TSHb antibody. 17 Reovirus infection of mice Reovirus serotype 3 Dearing strain (T3D reovirus) was purchased from the American Type Culture Collection. Virus stocks were grown as described previously. 32 Mice were infected i.p. with 10 7.5 PFU T3D reovirus or with PBS to serve as noninfected control animals. Two days postinfection, mice were euthanized, thyroid tissues were recovered and used for RNA extraction for qRT-PCR analysis with native and splice variant primers.
Statistical analyses
Determination of statistical significance was carried out by the analysis of variance or by a t-test for two samples with unequal variance.
